
    
      Each subject will receive a single oral dose of Lu AF35700 on Day 1 in each Period. Subjects
      in Group 1 will be in fasting condition in Period I and in a fed condition in Period II.
      Subjects in Group 2 will be in fed condition in Period I and in fasting condition in Period
      II.

      For Group 1, period 1 only, a single intravenous micro-dose of Lu AF35700 will be given 4
      hours after oral dosing.

      All subjects will be confined to the clinic from one day prior to the first dosing until Day
      6 (120 hours post dose) for each dosing period. Periods I and II will be separated by a
      period of 6 weeks.
    
  